Brenntag (BNR) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
8 Jul, 2026Executive summary
Q2 2024 sales reached EUR 4.2 billion, down 2% year-over-year, with operating EBITA at EUR 297 million, a 10.4% decline, and EPS at EUR 1.03, compared to EUR 1.23 in Q2 2023.
Free cash flow dropped to EUR 158 million in Q2 2024, a 63.5% decrease, mainly due to higher working capital investments.
Intense competition, margin stabilization initiatives, and ongoing strategy execution characterized the quarter.
H1 2024 results were impacted by a challenging market, with operating EBITA down 17.3% to EUR 556.8 million and sales down 6.6% on a constant currency basis.
Several acquisitions and a share buyback were completed, and EUR 1 billion in new bonds were issued.
Financial highlights
Q2 2024 sales: EUR 4.2 billion, down 2% year-over-year; operating gross profit: EUR 1.03 billion, up 0.6%; operating EBITA: EUR 297 million, down 10.4%.
Q2 2024 net profit after tax: EUR 151 million; EPS: EUR 1.03 (vs. EUR 1.23 in Q2 2023).
H1 2024 sales: EUR 8,178.9 million, down 6.9%; operating EBITA: EUR 556.8 million, down 17.3%; EPS: EUR 2.00 (vs. EUR 2.62 in H1 2023).
Free cash flow: EUR 158 million in Q2 2024 (down from EUR 432 million in Q2 2023); EUR 332.8 million in H1 2024 (down from EUR 880.9 million in H1 2023).
Net financial liabilities increased to EUR 2.86 billion at Q2 end.
Outlook and guidance
FY 2024 operating EBITA guidance revised to EUR 1.1–1.2 billion, down from EUR 1.23–1.43 billion.
Market conditions expected to remain highly competitive with continued pricing pressure and less supportive volume trends in H2 2024.
Anticipates stable gross profit per unit and only slight sequential volume improvement in H2 2024.
Capex for 2024 projected at EUR 350 million; tax rate expected at 29–31%.
Sequential improvement in demand expected to continue into 2025, with better pricing environment anticipated.
Latest events from Brenntag
- One customer-centered platform targets above-market growth, ~10% margins and >12% ROIC.BNR
CMD 2026 - Q3 EBITDA rose 14.5% FX-adjusted; FY26 guidance held toward the upper end.BNR
Q3 2026 (Pre recorded) - Q3 earnings grew and FY guidance held toward the upper end despite volatile costs.BNR
Q3 2026 - Strong Q2 2026 growth, margin expansion, and ESG leadership reinforce global market position.BNR
Investor presentation - Q2 EBITDA surged 41% and guidance was raised, despite persistent macroeconomic risks.BNR
Q2 2026 (Pre Recorded) - Q2 2026 delivered strong sales, profit growth, and raised guidance amid market volatility.BNR
Q2 2026 - Gross margin rose to 25.9% as sales fell 5.1% and EBITDA dropped 8.3% in Q1 2026.BNR
Q1 2026 - Sales and gross profit rose, but EBITA, EPS, and free cash flow declined in a tough Q3.BNR
Q3 2024 - 2024 EBITDA fell 13% to €1.1bn; 2025 outlook expects moderate recovery amid uncertainty.BNR
Q4 2024